effects [qlco]
Haemostasis [ortf]
Hormone replacement therapy [topp]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
Oral [spco]
Sequential [idcn]
medroxyprogesterone acetate [horm, phsu, strd]
Double-Blind Study [resa]
placebo-controlled [resa]
Menopause [phsf]
haemostatic [ortf]
Balance [orgf]
Shift [ftcn]
Latent [qlco]
Hypercoagulable state [dsyn]
Evaluate [ftcn]
effects [qlco]
regimens [inpr]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
E2 [gngm]
Combined [qlco]
Pro [aapp, bacs]
Balance [orgf]
Procoagulant [aapp, bacs]
inhibitors [chvf]
Women [popg]
Physiological [ftcn]
Menopause [phsf]
treatment [ftcn]
Cyclic [tmco]
Transdermal [ftcn]
E2 [gngm]
MU/day [qnco]
days [tmco]
Plus [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
mg day [qnco]
days [tmco]
Continuous [idcn]
Transdermal [ftcn]
E2 [gngm]
MU/day [qnco]
days [tmco]
Plus [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
mg day [qnco]
days [tmco]
placebo [topp]
Fibrinogen [aapp, bacs, phsu]
Factor VII [aapp, bacs, phsu]
Factor VIII [aapp, bacs, phsu]
Antithrombin III [aapp, phsu]
Protein C [aapp, bacs, phsu]
Protein S [aapp, bacs]
Heparin Co-Factor II [aapp, bacs, phsu]
Plasminogen activator inhibitor [aapp, bacs]
Levels [qlco]
Measured [qlco]
baseline [bodm]
Cycle [tmco]
Women [popg]
Take [hlca]
treatment [ftcn]
Cycle [tmco]
Evaluable [dsyn]
Continuous [idcn]
treatment [ftcn]
Group [idcn]
Final [tmco]
Values [qlco]
Fibrinogen [aapp, bacs, phsu]
Factor VII [aapp, bacs, phsu]
Antithrombin III [aapp, phsu]
Protein S [aapp, bacs]
Heparin Co-Factor II [aapp, bacs, phsu]
placebo [topp]
Group [idcn]
Cyclic [tmco]
treatment [ftcn]
Reduced [qlco]
Fibrinogen [aapp, bacs, phsu]
Comparison [acty]
placebo [topp]
Not significant [fndg]
regimens [inpr]
Relevant [qlco]
Decrease [qlco]
fibrinogen levels [lbpr]
Continuous [idcn]
Regimen [topp]
Affect [menp]
Levels [qlco]
Factor VII [aapp, bacs, phsu]
inhibitors [chvf]
Suggest [idcn]
haemostatic [ortf]
Balance [orgf]
shifted [ftcn]
Physiological [ftcn]
State [geoa]
